Literature DB >> 20833651

Ablation of phospholamban and sarcolipin results in cardiac hypertrophy and decreased cardiac contractility.

Mayilvahanan Shanmugam1, Shumin Gao, Chull Hong, Nadezhda Fefelova, Martha C Nowycky, Lai-Hua Xie, Muthu Periasamy, Gopal J Babu.   

Abstract

AIMS: Improving the sarco(endo)plasmic reticulum (SR) Ca(2+)-ATPase (SERCA) function has clinical implications in treating heart failure. The present study aimed to determine the effect of constitutive activation of the SERCA pump on cardiac contractility in normal mice and during pressure-overload-induced cardiac hypertrophy. METHODS AND
RESULTS: The SERCA pump was constitutively activated in both atrial and ventricular chambers of the mouse heart by ablating its key regulators, phospholamban (PLN) and sarcolipin (SLN). The double-knockout (dKO) mice for PLN and SLN showed increased SERCA pump activity, Ca(2+) transients and SR Ca(2+) load, and developed cardiac hypertrophy. Echocardiographic measurements showed that the basal cardiac function was not affected in the young dKO mice. However, the cardiac function worsened upon ageing and when subjected to pressure overload.
CONCLUSION: Our studies suggest that the constitutive activation of the SERCA pump is detrimental to cardiac function. Our findings also emphasize the need for dynamic regulation of the SERCA pump by PLN and/or SLN to maintain cardiac contractility in normal conditions and during pathophysiological states.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833651      PMCID: PMC3020129          DOI: 10.1093/cvr/cvq294

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  42 in total

1.  Akt1 is required for physiological cardiac growth.

Authors:  Brian DeBosch; Iya Treskov; Traian S Lupu; Carla Weinheimer; Attila Kovacs; Michael Courtois; Anthony J Muslin
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

2.  A SERCA2 pump with an increased Ca2+ affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life span.

Authors:  Peter Vangheluwe; Marc Tjwa; An Van Den Bergh; William E Louch; Monique Beullens; Leonard Dode; Peter Carmeliet; Evangelia Kranias; Paul Herijgers; Karin R Sipido; Luc Raeymaekers; Frank Wuytack
Journal:  J Mol Cell Cardiol       Date:  2006-06-30       Impact factor: 5.000

3.  Phospholamban deficiency alters inactivation kinetics of L-type Ca2+ channels in mouse ventricular myocytes.

Authors:  H Masaki; Y Sato; W Luo; E G Kranias; A Yatani
Journal:  Am J Physiol       Date:  1997-02

Review 4.  Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway.

Authors:  Ichiro Shiojima; Kenneth Walsh
Journal:  Genes Dev       Date:  2006-12-15       Impact factor: 11.361

5.  Excessive sarcoplasmic/endoplasmic reticulum Ca2+-ATPase expression causes increased sarcoplasmic reticulum Ca2+ uptake but decreases myocyte shortening.

Authors:  Nils Teucher; Juergen Prestle; Tim Seidler; Susan Currie; Elspeth B Elliott; Deborah F Reynolds; Peter Schott; Stefan Wagner; Harald Kogler; Giuseppe Inesi; Donald M Bers; Gerd Hasenfuss; Godfrey L Smith
Journal:  Circulation       Date:  2004-10-25       Impact factor: 29.690

Review 6.  Altered cardiac calcium handling in diabetes.

Authors:  Darrell D Belke; Wolfgang H Dillmann
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

7.  Down-regulation of sarcolipin mRNA expression in chronic atrial fibrillation.

Authors:  N Uemura; T Ohkusa; K Hamano; M Nakagome; H Hori; M Shimizu; M Matsuzaki; S Mochizuki; S Minamisawa; Y Ishikawa
Journal:  Eur J Clin Invest       Date:  2004-11       Impact factor: 4.686

Review 8.  New perspectives on the role of SERCA2's Ca2+ affinity in cardiac function.

Authors:  P Vangheluwe; K R Sipido; L Raeymaekers; F Wuytack
Journal:  Biochim Biophys Acta       Date:  2006-08-25

9.  Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts.

Authors:  G Chu; W Luo; J P Slack; C Tilgmann; W E Sweet; M Spindler; K W Saupe; G P Boivin; C S Moravec; M A Matlib; I L Grupp; J S Ingwall; E G Kranias
Journal:  Circ Res       Date:  1996-12       Impact factor: 17.367

Review 10.  Molecular aspects of adrenergic modulation of cardiac L-type Ca2+ channels.

Authors:  Marcel A G van der Heyden; Tessa J M Wijnhoven; Tobias Opthof
Journal:  Cardiovasc Res       Date:  2005-01-01       Impact factor: 10.787

View more
  20 in total

1.  Calcium handling proteins: structure, function, and modulation by exercise.

Authors:  Jamille Locatelli; Leonardo V M de Assis; Mauro C Isoldi
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

Review 2.  Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium.

Authors:  Francesco S Loffredo; Andriana P Nikolova; James R Pancoast; Richard T Lee
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

3.  Acetylation of SERCA2a, Another Target for Heart Failure Treatment?

Authors:  Xiongwen Chen; Xiaoying Zhang; Scott Gross; Steven R Houser; Jonathan Soboloff
Journal:  Circ Res       Date:  2019-04-26       Impact factor: 17.367

4.  Afterdepolarizations and abnormal calcium handling in atrial myocytes with modulated SERCA uptake: a sensitivity analysis of calcium handling channels.

Authors:  Andy C Y Lo; Jieyun Bai; Patrick A Gladding; Vadim V Fedorov; Jichao Zhao
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2020-05-25       Impact factor: 4.226

5.  Decreased sarcolipin protein expression and enhanced sarco(endo)plasmic reticulum Ca2+ uptake in human atrial fibrillation.

Authors:  Mayilvahanan Shanmugam; Cristina E Molina; Shumin Gao; Renaud Severac-Bastide; Rodolphe Fischmeister; Gopal J Babu
Journal:  Biochem Biophys Res Commun       Date:  2011-05-25       Impact factor: 3.575

6.  Tuning the structural coupling between the transmembrane and cytoplasmic domains of phospholamban to control sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) function.

Authors:  Kim N Ha; Martin Gustavsson; Gianluigi Veglia
Journal:  J Muscle Res Cell Motil       Date:  2012-09-13       Impact factor: 2.698

7.  HuR regulates phospholamban expression in isoproterenol-induced cardiac remodelling.

Authors:  Han Hu; Mingyang Jiang; Yangpo Cao; Zhuojun Zhang; Bin Jiang; Feng Tian; Juan Feng; Yali Dou; Myriam Gorospe; Ming Zheng; Lemin Zheng; Zhongzhou Yang; Wengong Wang
Journal:  Cardiovasc Res       Date:  2020-04-01       Impact factor: 10.787

Review 8.  Phospholamban and sarcolipin: Are they functionally redundant or distinct regulators of the Sarco(Endo)Plasmic Reticulum Calcium ATPase?

Authors:  Sana A Shaikh; Sanjaya K Sahoo; Muthu Periasamy
Journal:  J Mol Cell Cardiol       Date:  2015-12-29       Impact factor: 5.000

Review 9.  Alterations in ryanodine receptors and related proteins in heart failure.

Authors:  Sameer Ather; Jonathan L Respress; Na Li; Xander H T Wehrens
Journal:  Biochim Biophys Acta       Date:  2013-06-14

10.  Nitric oxide signalling pathway in Duchenne muscular dystrophy mice: up-regulation of L-arginine transporters.

Authors:  Jayalakshmi Ramachandran; Joel S Schneider; Pierre-Antoine Crassous; Ruifang Zheng; James P Gonzalez; Lai-Hua Xie; Annie Beuve; Diego Fraidenraich; R Daniel Peluffo
Journal:  Biochem J       Date:  2013-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.